A large scientific litterature supports the potential of Multiparametric Magnetic Resonnance Imaging (mpMRI) for the detection of prostate cancer. This innovation has been well validated in research projects but the necessary conditions for its implementation in the Quebec healthcare system remain to be defined.

The main objective of this project is to assess the feasibility of introducing a new prostate cancer diagnostic care path that includes mpMRI in a real-life context at the CHU de Québec-Université Laval. The interest for introducing this innovation in the Quebec health care system is demonstrated by the request from the Direction générale de cancérologie du Ministère de la Santé et des Services sociaux (MSSS) to Institut national d’excellence en santé et en services sociaux (INESSS) to provide an advice concerning the efficacy and safety of mpMRI for the diagnosis of prostate cancer and the relevance of including it in the quebec cancer care offering.

The present request is to finance the work to caracterise this new diagnostic trajectory, to evaluate its clinical impacts, organisationnal and financial, and to determine the issues and challenges associated with its implementation in the quebec context. The integration of mpMRI may bring several clinical benefits including a better selection of patients requiring prostate biopsies and a reduction of adverse events related to it. Financial impacts associated with this new trajectory are to be expected and will be documented.